🔎 Trials Near Me

홈 › 만성 폐쇄성 폐질환 › 오클라호마

오클라호마의 만성 폐쇄성 폐질환 임상 시험

만성 폐쇄성 폐질환 관련 연구 9개가 오클라호마 내 여러 지역에서 참여자를 모집하고 있습니다.

오클라호마의 도시

공식 연구 텍스트(영어)

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

  • Research Site, Oklahoma City
  • Research Site, Tulsa
피험자 모집 중2상
40세 이상 · 모든 성별 · 2026. 10. 23. 업데이트됨 · NCT07082738

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

  • Layrek Clinical Research- Site Number : 8400066, Tulsa
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 10. 23. 업데이트됨 · NCT07190222

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

  • Layrek Clinical Research, Tulsa
피험자 모집 중2/3상
35세 ~ 80세 · 모든 성별 · 2026. 10. 22. 업데이트됨 · NCT07363694

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

  • Epic Medical Research - Chickasha- Site Number : 8400097, Chickasha
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 10. 19. 업데이트됨 · NCT07190209

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

  • Research Site, Oklahoma City
  • Research Site, Tulsa
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 10. 9. 업데이트됨 · NCT06878261

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

  • Research Site, Norman
  • Research Site, Oklahoma City
  • Research Site, Tulsa
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT06283966

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

  • Research Site, Oklahoma City
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT06883305

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

  • GSK Investigational Site, Edmond
피험자 모집 중3상
40세 ~ 75세 · 모든 성별 · 2026. 7. 28. 업데이트됨 · NCT07177339

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

  • Hightower Clinical, Oklahoma City
피험자 모집 중관찰 연구
50세 이상 · 모든 성별 · 2025. 8. 5. 업데이트됨 · NCT06122077

ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.